T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.350
+0.016 (4.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
T2 Biosystems Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -42.95 | -50.08 | -62 | -49.24 | -46.8 | -59.01 | Upgrade
|
| Depreciation & Amortization | 0.26 | 0.86 | 1.05 | 2.54 | 3.16 | 3.64 | Upgrade
|
| Other Amortization | - | 0.68 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | 0 | - | - | -0 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 2.51 | 0.15 | - | 1.16 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0 | 0.14 | 0.07 | - | Upgrade
|
| Stock-Based Compensation | 2.75 | 4.35 | 6.49 | 7.09 | 3.91 | 5.46 | Upgrade
|
| Other Operating Activities | 0.89 | -2.42 | 4.18 | 2.77 | 1.82 | 2.69 | Upgrade
|
| Change in Accounts Receivable | -0.89 | 0.74 | 2.97 | -0.04 | -2.27 | -1.04 | Upgrade
|
| Change in Inventory | 0.79 | -0.74 | -0.95 | -1.94 | 0.44 | -0.91 | Upgrade
|
| Change in Accounts Payable | 3.12 | 0.23 | -1.57 | 0.76 | -1.65 | 2.96 | Upgrade
|
| Change in Unearned Revenue | -0.02 | 0.08 | -0.32 | -0.11 | 0.32 | -0.5 | Upgrade
|
| Change in Other Net Operating Assets | -0.54 | -4.36 | -0.64 | -0.85 | -3.38 | 1.35 | Upgrade
|
| Operating Cash Flow | -36.59 | -48.14 | -50.63 | -38.87 | -43.22 | -45.36 | Upgrade
|
| Capital Expenditures | -0.03 | -0.19 | -0.34 | -0.46 | -0.8 | -0.76 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Investment in Securities | - | - | 10 | 25.25 | -35.46 | - | Upgrade
|
| Investing Cash Flow | -0.03 | -0.19 | 9.66 | 24.79 | -36.26 | -0.76 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -0.88 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.88 | Upgrade
|
| Issuance of Common Stock | 14.38 | 52.75 | 29.33 | 20.54 | 85.61 | 7.23 | Upgrade
|
| Repurchase of Common Stock | -0 | - | -0.24 | - | - | - | Upgrade
|
| Other Financing Activities | - | -0.06 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 14.38 | 52.69 | 29.05 | 20.54 | 85.61 | 6.35 | Upgrade
|
| Net Cash Flow | -22.24 | 4.36 | -11.92 | 6.45 | 6.13 | -39.77 | Upgrade
|
| Free Cash Flow | -36.62 | -48.33 | -50.97 | -39.33 | -44.02 | -46.12 | Upgrade
|
| Free Cash Flow Margin | -476.98% | -671.88% | -228.50% | -140.19% | -242.80% | -553.35% | Upgrade
|
| Free Cash Flow Per Share | -3.48 | -18.52 | -999.31 | -1238.01 | -1814.02 | - | Upgrade
|
| Cash Interest Paid | 2.07 | 3.86 | 3.92 | 3.81 | 3.69 | 4.66 | Upgrade
|
| Levered Free Cash Flow | -26.37 | -23.07 | -29.62 | -21.33 | -30.45 | -25.37 | Upgrade
|
| Unlevered Free Cash Flow | -24.37 | -19.73 | -25.82 | -16.58 | -27 | -20.78 | Upgrade
|
| Change in Net Working Capital | 1.36 | -4.01 | -1.39 | -1.11 | 8.15 | -3.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.